Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats
Authors:
- 1 October 1994
- journal article
- contemporary techniques
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 14 (5) , 579-588
Abstract
1. The neuropeptide corticotropin-releasing hormone (CRH) is the main mediator of the neuroendocrine and behavioral response to stress. End-capped phosphorothioate antisense and sense oligodeoxynucleotides (ODN) corresponding to the start coding region of rat CRH mRNA were infused intracerebroventricularly (30 µg/3 μl per injection) three times at 12 hr intervals. Six hours after the last injection rats were subjected to social defeat stress and subsequently tested on the elevated plus maze. 2. Socially defeated CRH antisense-treated rats displayed markedly reduced anxiety-related behavior, as they spent significantly more time in the open arms of the plus maze compared to sense ODN- and vehicle-treated animals. 3. In controls, social defeat evoked a stress-induced elevation of CRH mRNA and CRH in the hypothalamus and a significant increase in plasma corticotropin (ACTH) levels. These parameters were attenuated in antisense-injected rats. 4. Our results suggest that CRH antisense treatment is effectively suppressing the neuroendocrine and behavioral effects of social defeat.Keywords
This publication has 29 references indexed in Scilit:
- Antisense oligodeoxynucleotide complementary to oxytocin mRNA blocks lactation in ratsExperimental and Clinical Endocrinology & Diabetes, 1995
- Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in ratNeuroReport, 1994
- Antisense Oligodeoxynucleotides for In Vivo Targeting of Corticotropin-Releasing Hormone mRNA: Comparison of Phosphorothioate and 3′-Inverted Probe PerformanceHormone and Metabolic Research, 1994
- Vasopressin Antisense Oligonucleotide Induces Temporary Diabetes Insipidus in RatsJournal of Neuroendocrinology, 1994
- Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense OligodeoxynucleotidesScience, 1993
- Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?Brain Research Reviews, 1990
- Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the ratJournal of Comparative Neurology, 1989
- Animal models for the study of anti-anxiety agents: A reviewNeuroscience & Biobehavioral Reviews, 1985
- Organization of Ovine Corticotropin-Releasing Factor Immunoreactive Cells and Fibers in the Rat Brain: An Immunohistochemical StudyNeuroendocrinology, 1983
- Intraventricular corticotropin-releasing factor enhances behavioral effects of noveltyLife Sciences, 1982